Lisata Therapeutics Inc.
LSTA | NASDAQ
$1.60
+$0.04 (+2.56%)
Sep 22, 2026, 12:34 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.97 | -1.24 | -1.06 | -0.24 | -1.69 | -2.71 |
PEG Ratio | 0.05 | 0.18 | 0.01 | -0.01 | 0.29 | 0.04 |
PS Ratio | 95.05 | 24.82 | n/a | n/a | n/a | n/a |
PB Ratio | 1.09 | 0.84 | 0.46 | 0.20 | 0.50 | 0.68 |
P/FCF Ratio | -1.01 | -1.28 | -1.10 | -0.61 | -2.08 | -2.50 |
P/OCF Ratio | -1.01 | -1.28 | -1.10 | -0.62 | -2.09 | -2.50 |
OCF/S Ratio | -9.38K | -1.94K | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0 | 0 | 0.01 | 0.01 | 0.02 |
Quick Ratio | 5.76 | 6.16 | 8.18 | 11.26 | 21.27 | 10.08 |
Current Ratio | 5.76 | 6.16 | 8.18 | 11.26 | 21.27 | 10.08 |
Asset Turnover | 0.01 | 0.03 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -111.65% | -67.58% | -43.28% | -81.45% | -29.77% | -25.08% |
Return on Assets | -93.47% | -57.10% | -38.10% | -74.25% | -28.31% | -22.64% |
Return on Invested Capital | -117.30% | -72.98% | -47.90% | -82.42% | -29.70% | -24.94% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 14.12% | 100% | n/a | n/a | n/a | n/a |
Net Profit Margin | -9.76K% | -2K% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -10.32K% | -2.08K% | n/a | n/a | n/a | n/a |
Operating Profit Margin | -10.71K% | -2.24K% | n/a | n/a | n/a | n/a |
FCF Margin | -9.4K% | -1.94K% | n/a | n/a | n/a | n/a |
EBITDA Margin | -10.24K% | -2.06K% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove LSTA